Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Neighborhood Poverty and Sex Differences in Live Donor Kidney Transplant Outcomes in the United States.

Purnell TS, Luo X, Crews DC, Bae S, Ruck JM, Cooper LA, Grams ME, Henderson ML, Waldram MM, Johnson M, Segev DL.

Transplantation. 2019 Feb 6. doi: 10.1097/TP.0000000000002654. [Epub ahead of print]

PMID:
30768570
2.

Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial.

Rebholz CM, Zheng Z, Grams ME, Appel LJ, Sarnak MJ, Inker LA, Levey AS, Coresh J.

Am J Clin Nutr. 2019 Feb 8. doi: 10.1093/ajcn/nqy202. [Epub ahead of print]

PMID:
30753252
3.

Serum Metabolomic Alterations Associated with Proteinuria in CKD.

Luo S, Coresh J, Tin A, Rebholz CM, Appel LJ, Chen J, Vasan RS, Anderson AH, Feldman HI, Kimmel PL, Waikar SS, Köttgen A, Evans AM, Levey AS, Inker LA, Sarnak MJ, Grams ME; Chronic Kidney Disease Biomarkers Consortium Investigators.

Clin J Am Soc Nephrol. 2019 Feb 7. pii: CJN.10010818. doi: 10.2215/CJN.10010818. [Epub ahead of print]

PMID:
30733224
4.

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.

Coresh J, Heerspink HJL, Sang Y, Matsushita K, Arnlov J, Astor BC, Black C, Brunskill NJ, Carrero JJ, Feldman HI, Fox CS, Inker LA, Ishani A, Ito S, Jassal S, Konta T, Polkinghorne K, Romundstad S, Solbu MD, Stempniewicz N, Stengel B, Tonelli M, Umesawa M, Waikar SS, Wen CP, Wetzels JFM, Woodward M, Grams ME, Kovesdy CP, Levey AS, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium and Chronic Kidney Disease Epidemiology Collaboration.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):115-127. doi: 10.1016/S2213-8587(18)30313-9. Epub 2019 Jan 8.

PMID:
30635225
5.

Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium.

Chang AR, Grams ME, Ballew SH, Bilo H, Correa A, Evans M, Gutierrez OM, Hosseinpanah F, Iseki K, Kenealy T, Klein B, Kronenberg F, Lee BJ, Li Y, Miura K, Navaneethan SD, Roderick PJ, Valdivielso JM, Visseren FLJ, Zhang L, Gansevoort RT, Hallan SI, Levey AS, Matsushita K, Shalev V, Woodward M; CKD Prognosis Consortium (CKD-PC).

BMJ. 2019 Jan 10;364:k5301. doi: 10.1136/bmj.k5301.

6.

Elevated Vancomycin Trough Levels in a Tertiary Health System: Frequency, Risk Factors, and Prognosis.

Zonozi R, Wu A, Shin JI, Secora A, Coresh J, Inker LA, Chang AR, Grams ME.

Mayo Clin Proc. 2019 Jan;94(1):17-26. doi: 10.1016/j.mayocp.2018.08.034.

PMID:
30611444
7.

Prevalence of Opioid, Gabapentinoid, and NSAID Use in Patients with CKD.

Novick TK, Surapaneni A, Shin JI, Ballew SH, Alexander GC, Inker LA, Chang AR, Grams ME.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1886-1888. doi: 10.2215/CJN.08530718. Epub 2018 Nov 8. No abstract available.

PMID:
30409899
8.

Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium.

Inker LA, Grams ME, Levey AS, Coresh J, Cirillo M, Collins JF, Gansevoort RT, Gutierrez OM, Hamano T, Heine GH, Ishikawa S, Jee SH, Kronenberg F, Landray MJ, Miura K, Nadkarni GN, Peralta CA, Rothenbacher D, Schaeffner E, Sedaghat S, Shlipak MG, Zhang L, van Zuilen AD, Hallan SI, Kovesdy CP, Woodward M, Levin A; CKD Prognosis Consortium.

Am J Kidney Dis. 2019 Feb;73(2):206-217. doi: 10.1053/j.ajkd.2018.08.013. Epub 2018 Oct 19.

PMID:
30348535
9.

Coffee consumption and liver-related hospitalizations and deaths in the ARIC study.

Hu EA, Lazo M, Selvin E, Hamilton JP, Grams ME, Steffen LM, Coresh J, Rebholz CM.

Eur J Clin Nutr. 2018 Oct 19. doi: 10.1038/s41430-018-0346-0. [Epub ahead of print]

PMID:
30341433
10.

Chronic kidney disease measures and the risk of abdominal aortic aneurysm.

Matsushita K, Kwak L, Ballew SH, Grams ME, Selvin E, Folsom AR, Coresh J, Tang W.

Atherosclerosis. 2018 Dec;279:107-113. doi: 10.1016/j.atherosclerosis.2018.08.043. Epub 2018 Sep 1.

PMID:
30290962
11.

Lactic Acidosis, Metformin Use, and Dose-Response Association-Reply.

Lazarus B, Shin JI, Grams ME.

JAMA Intern Med. 2018 Oct 1;178(10):1427-1428. doi: 10.1001/jamainternmed.2018.4430. No abstract available.

PMID:
30285140
12.

Proton Pump Inhibitors in Kidney Disease.

Lazarus B, Grams ME.

Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1458-1459. doi: 10.2215/CJN.10110818. Epub 2018 Sep 27. No abstract available.

PMID:
30262671
13.

Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study.

Oelsner EC, Balte PP, Grams ME, Cassano PA, Jacobs DR, Barr RG, Burkart KM, Kalhan R, Kronmal R, Loehr LR, O'Connor GT, Schwartz JE, Shlipak M, Tracy RP, Tsai MY, White W, Yende S.

Am J Respir Crit Care Med. 2019 Feb 1;199(3):321-332. doi: 10.1164/rccm.201803-0402OC.

PMID:
30261735
14.

Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults.

Secora A, Alexander GC, Ballew SH, Coresh J, Grams ME.

Drugs Aging. 2018 Aug;35(8):735-750. doi: 10.1007/s40266-018-0563-1.

PMID:
30039344
15.

Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation.

Shin JI, Secora A, Alexander GC, Inker LA, Coresh J, Chang AR, Grams ME.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1144-1152. doi: 10.2215/CJN.13811217. Epub 2018 Jul 12.

PMID:
30002224
16.

Prognostic Implications of Single-Sample Confirmatory Testing for Undiagnosed Diabetes: A Prospective Cohort Study.

Selvin E, Wang D, Matsushita K, Grams ME, Coresh J.

Ann Intern Med. 2018 Aug 7;169(3):156-164. doi: 10.7326/M18-0091. Epub 2018 Jun 19.

PMID:
29913486
17.

Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD.

Luo S, Coresh J, Tin A, Rebholz CM, Chen TK, Hayek SS, Tracy M, Lipkowitz MS, Appel LJ, Levey AS, Inker LA, Reiser J, Grams ME.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1013-1021. doi: 10.2215/CJN.13631217. Epub 2018 Jun 14.

PMID:
29903900
18.

Socioeconomic status and risk of kidney dysfunction: the Atherosclerosis Risk in Communities study.

Vart P, Grams ME, Ballew SH, Woodward M, Coresh J, Matsushita K.

Nephrol Dial Transplant. 2018 Jun 11. doi: 10.1093/ndt/gfy142. [Epub ahead of print]

PMID:
29897587
19.

Serum metabolites are associated with all-cause mortality in chronic kidney disease.

Hu JR, Coresh J, Inker LA, Levey AS, Zheng Z, Rebholz CM, Tin A, Appel LJ, Chen J, Sarnak MJ, Grams ME.

Kidney Int. 2018 Aug;94(2):381-389. doi: 10.1016/j.kint.2018.03.008. Epub 2018 Jun 2.

PMID:
29871777
20.

Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study.

Lazarus B, Wu A, Shin JI, Sang Y, Alexander GC, Secora A, Inker LA, Coresh J, Chang AR, Grams ME.

JAMA Intern Med. 2018 Jul 1;178(7):903-910. doi: 10.1001/jamainternmed.2018.0292.

PMID:
29868840
21.

Diabetes and Trajectories of Estimated Glomerular Filtration Rate: A Prospective Cohort Analysis of the Atherosclerosis Risk in Communities Study.

Warren B, Rebholz CM, Sang Y, Lee AK, Coresh J, Selvin E, Grams ME.

Diabetes Care. 2018 Aug;41(8):1646-1653. doi: 10.2337/dc18-0277. Epub 2018 Jun 1.

PMID:
29858211
22.

Risk Factors for Prognosis in Patients With Severely Decreased GFR.

Evans M, Grams ME, Sang Y, Astor BC, Blankestijn PJ, Brunskill NJ, Collins JF, Kalra PA, Kovesdy CP, Levin A, Mark PB, Moranne O, Rao P, Rios PG, Schneider MP, Shalev V, Zhang H, Chang AR, Gansevoort RT, Matsushita K, Zhang L, Eckardt KU, Hemmelgarn B, Wheeler DC.

Kidney Int Rep. 2018 Jan 11;3(3):625-637. doi: 10.1016/j.ekir.2018.01.002. eCollection 2018 May. Erratum in: Kidney Int Rep. 2018 Aug 30;3(6):1506.

23.

Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression.

Tin A, Nadkarni G, Evans AM, Winkler CA, Bottinger E, Rebholz CM, Sarnak MJ, Inker LA, Levey AS, Lipkowitz MS, Appel LJ, Arking DE, Coresh J, Grams ME.

J Am Soc Nephrol. 2018 Jul;29(7):1939-1947. doi: 10.1681/ASN.2017101064. Epub 2018 May 18.

PMID:
29777021
24.

Metabolomics Research in Chronic Kidney Disease.

Grams ME, Shafi T, Rhee EP.

J Am Soc Nephrol. 2018 Jun;29(6):1588-1590. doi: 10.1681/ASN.2018030256. Epub 2018 May 3. No abstract available.

PMID:
29724883
25.

Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Eckardt KU, Bansal N, Coresh J, Evans M, Grams ME, Herzog CA, James MT, Heerspink HJL, Pollock CA, Stevens PE, Tamura MK, Tonelli MA, Wheeler DC, Winkelmayer WC, Cheung M, Hemmelgarn BR; Conference Participants.

Kidney Int. 2018 Jun;93(6):1281-1292. doi: 10.1016/j.kint.2018.02.006. Epub 2018 Apr 12.

26.

Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.

Grams ME, Sang Y, Ballew SH, Carrero JJ, Djurdjev O, Heerspink HJL, Ho K, Ito S, Marks A, Naimark D, Nash DM, Navaneethan SD, Sarnak M, Stengel B, Visseren FLJ, Wang AY, Köttgen A, Levey AS, Woodward M, Eckardt KU, Hemmelgarn B, Coresh J.

Kidney Int. 2018 Jun;93(6):1442-1451. doi: 10.1016/j.kint.2018.01.009. Epub 2018 Mar 29. Erratum in: Kidney Int. 2018 Nov;94(5):1025-1026.

PMID:
29605094
27.

Coffee Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study.

Hu EA, Selvin E, Grams ME, Steffen LM, Coresh J, Rebholz CM.

Am J Kidney Dis. 2018 Aug;72(2):214-222. doi: 10.1053/j.ajkd.2018.01.030. Epub 2018 Mar 20.

PMID:
29571833
28.

Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis.

Kovesdy CP, Matsushita K, Sang Y, Brunskill NJ, Carrero JJ, Chodick G, Hasegawa T, Heerspink HL, Hirayama A, Landman GWD, Levin A, Nitsch D, Wheeler DC, Coresh J, Hallan SI, Shalev V, Grams ME; CKD Prognosis Consortium .

Eur Heart J. 2018 May 1;39(17):1535-1542. doi: 10.1093/eurheartj/ehy100.

PMID:
29554312
29.

Kidney Function in Obesity-Challenges in Indexing and Estimation.

Chang AR, Zafar W, Grams ME.

Adv Chronic Kidney Dis. 2018 Jan;25(1):31-40. doi: 10.1053/j.ackd.2017.10.007. Review.

30.

Metabolically Healthy Obesity and Risk of Kidney Function Decline.

Chang AR, Surapaneni A, Kirchner HL, Young A, Kramer HJ, Carey DJ, Appel LJ, Grams ME.

Obesity (Silver Spring). 2018 Apr;26(4):762-768. doi: 10.1002/oby.22134. Epub 2018 Mar 2.

31.

Hemoglobin, Albuminuria, and Kidney Function in Cardiovascular Risk: The ARIC (Atherosclerosis Risk in Communities) Study.

Ishigami J, Grams ME, Naik RP, Caughey MC, Loehr LR, Uchida S, Coresh J, Matsushita K.

J Am Heart Assoc. 2018 Jan 12;7(2). pii: e007209. doi: 10.1161/JAHA.117.007209.

32.

Direct Oral Anticoagulants and Risk of Acute Kidney Injury in Patients With Atrial Fibrillation.

Shin JI, Luo S, Alexander GC, Inker LA, Coresh J, Chang AR, Grams ME.

J Am Coll Cardiol. 2018 Jan 16;71(2):251-252. doi: 10.1016/j.jacc.2017.10.089. No abstract available.

33.

Epigenome-wide association studies identify DNA methylation associated with kidney function.

Chu AY, Tin A, Schlosser P, Ko YA, Qiu C, Yao C, Joehanes R, Grams ME, Liang L, Gluck CA, Liu C, Coresh J, Hwang SJ, Levy D, Boerwinkle E, Pankow JS, Yang Q, Fornage M, Fox CS, Susztak K, Köttgen A.

Nat Commun. 2017 Nov 3;8(1):1286. doi: 10.1038/s41467-017-01297-7.

34.

Potassium homeostasis in health and disease: A scientific workshop cosponsored by the National Kidney Foundation and the American Society of Hypertension.

Kovesdy CP, Appel LJ, Grams ME, Gutekunst L, McCullough PA, Palmer BF, Pitt B, Sica DA, Townsend RR.

J Am Soc Hypertens. 2017 Dec;11(12):783-800. doi: 10.1016/j.jash.2017.09.011. Epub 2017 Oct 10. Review.

PMID:
29030153
35.

Potassium Homeostasis in Health and Disease: A Scientific Workshop Cosponsored by the National Kidney Foundation and the American Society of Hypertension.

Kovesdy CP, Appel LJ, Grams ME, Gutekunst L, McCullough PA, Palmer BF, Pitt B, Sica DA, Townsend RR.

Am J Kidney Dis. 2017 Dec;70(6):844-858. doi: 10.1053/j.ajkd.2017.09.003. Epub 2017 Oct 10.

PMID:
29029808
36.

Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study.

Ishigami J, Jaar BG, Rebholz CM, Grams ME, Michos ED, Wolf M, Kovesdy CP, Uchida S, Coresh J, Lutsey PL, Matsushita K.

J Clin Endocrinol Metab. 2017 Dec 1;102(12):4648-4657. doi: 10.1210/jc.2017-01868.

37.

Metabolomic Alterations Associated with Cause of CKD.

Grams ME, Tin A, Rebholz CM, Shafi T, Köttgen A, Perrone RD, Sarnak MJ, Inker LA, Levey AS, Coresh J.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1787-1794. doi: 10.2215/CJN.02560317. Epub 2017 Sep 28.

38.

Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.

Rebholz CM, Selvin E, Liang M, Ballantyne CM, Hoogeveen RC, Aguilar D, McEvoy JW, Grams ME, Coresh J.

Kidney Int. 2018 Jan;93(1):252-259. doi: 10.1016/j.kint.2017.06.028. Epub 2017 Aug 31.

39.

Proton Pump Inhibitors and Kidney Disease - GI Upset for the Nephrologist?

Toth-Manikowski S, Grams ME.

Kidney Int Rep. 2017 May;2(3):297-301. doi: 10.1016/j.ekir.2017.01.005. Epub 2017 Jan 23.

40.

Acute Kidney Injury in Patients on SGLT2 Inhibitors: A Propensity-Matched Analysis.

Nadkarni GN, Ferrandino R, Chang A, Surapaneni A, Chauhan K, Poojary P, Saha A, Ferket B, Grams ME, Coca SG.

Diabetes Care. 2017 Nov;40(11):1479-1485. doi: 10.2337/dc17-1011. Epub 2017 Aug 21.

41.

Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study.

Sumida K, Kwak L, Grams ME, Yamagata K, Punjabi NM, Kovesdy CP, Coresh J, Matsushita K.

Am J Kidney Dis. 2017 Nov;70(5):675-685. doi: 10.1053/j.ajkd.2017.05.021. Epub 2017 Jul 26.

42.

Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system.

Nilsson E, Gasparini A, Ärnlöv J, Xu H, Henriksson KM, Coresh J, Grams ME, Carrero JJ.

Int J Cardiol. 2017 Oct 15;245:277-284. doi: 10.1016/j.ijcard.2017.07.035. Epub 2017 Jul 15.

43.

Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project.

Bandak G, Sang Y, Gasparini A, Chang AR, Ballew SH, Evans M, Arnlov J, Lund LH, Inker LA, Coresh J, Carrero JJ, Grams ME.

J Am Heart Assoc. 2017 Jul 19;6(7). pii: e005428. doi: 10.1161/JAHA.116.005428.

44.

The Loss of GSTM1 Associates with Kidney Failure and Heart Failure.

Tin A, Scharpf R, Estrella MM, Yu B, Grove ML, Chang PP, Matsushita K, Köttgen A, Arking DE, Boerwinkle E, Le TH, Coresh J, Grams ME.

J Am Soc Nephrol. 2017 Nov;28(11):3345-3352. doi: 10.1681/ASN.2017030228. Epub 2017 Jul 18.

45.

Association between Endothelin-1 Levels and Kidney Disease among Blacks.

Rebholz CM, Harman JL, Grams ME, Correa A, Shimbo D, Coresh J, Young BA.

J Am Soc Nephrol. 2017 Nov;28(11):3337-3344. doi: 10.1681/ASN.2016111236. Epub 2017 Jul 11.

46.

A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease.

Hayek SS, Koh KH, Grams ME, Wei C, Ko YA, Li J, Samelko B, Lee H, Dande RR, Lee HW, Hahm E, Peev V, Tracy M, Tardi NJ, Gupta V, Altintas MM, Garborcauskas G, Stojanovic N, Winkler CA, Lipkowitz MS, Tin A, Inker LA, Levey AS, Zeier M, Freedman BI, Kopp JB, Skorecki K, Coresh J, Quyyumi AA, Sever S, Reiser J.

Nat Med. 2017 Aug;23(8):945-953. doi: 10.1038/nm.4362. Epub 2017 Jun 26.

47.

Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease.

Klatte DCF, Gasparini A, Xu H, de Deco P, Trevisan M, Johansson ALV, Wettermark B, Ärnlöv J, Janmaat CJ, Lindholm B, Dekker FW, Coresh J, Grams ME, Carrero JJ.

Gastroenterology. 2017 Sep;153(3):702-710. doi: 10.1053/j.gastro.2017.05.046. Epub 2017 Jun 2.

PMID:
28583827
48.

APOL1 Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension).

Chen TK, Appel LJ, Grams ME, Tin A, Choi MJ, Lipkowitz MS, Winkler CA, Estrella MM.

Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1765-1769. doi: 10.1161/ATVBAHA.117.309384. Epub 2017 Jun 1.

49.

Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease.

Rebholz CM, Grams ME, Chen Y, Gross AL, Sang Y, Coresh J, Selvin E.

Am J Epidemiol. 2017 Oct 15;186(8):952-960. doi: 10.1093/aje/kwx167.

50.

Bariatric Surgery and Kidney-Related Outcomes.

Chang AR, Grams ME, Navaneethan SD.

Kidney Int Rep. 2017 Mar;2(2):261-270. doi: 10.1016/j.ekir.2017.01.010. Epub 2017 Jan 26.

Supplemental Content

Loading ...
Support Center